Physician profile
William B Johnson
NPI 1346680709
$23,242.12
in general payments reported to CMS, 2019-2025
15 companies · $2,500 in 2025
The $2,500 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $288 · 2021: $116 · 2022: $226 · 2023: $75.30 · 2024: $6,907 · 2025: $2,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Travel and Lodging: $3,674 · Consulting Fee: $1,060 · Food and Beverage: $615 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Travel and Lodging | $3,674.43 |
| Consulting Fee | $1,060.00 |
| Food and Beverage | $615.31 |
| Education | $132.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,778.31 | 2019-2025 | Persona |
| Smith+Nephew, INC. | $5,646.92 | 2019 | |
| Medical Device Business Services, INC. | $5,490.36 | 2019-2025 | |
| Medtronic, INC. | $4,000.00 | 2024 | Endurant Iis |
| Canary Medical USA LLC | $500.00 | 2024 | |
| Depuy Synthes Sales INC. | $310.68 | 2019-2025 | Attune, Reclaim |
| Medacta USA, INC. | $198.76 | 2023-2025 | Gmk Sphere |
| Pacira Therapeutics, INC. | $112.62 | 2020 | |
| Nalu Medical, INC. | $73.26 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $38.96 | 2022-2023 | Exparel, Zilretta, Iovera |
| Sanofi Pasteur INC. | $31.90 | 2019 | |
| Solventum Corporation | $19.61 | 2025 | Prevena |
| Teva Pharmaceuticals USA, INC. | $14.76 | 2020 | |
| Allergan, INC. | $13.01 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.